Tech-enabled medication management company Scriptology announced that it has acquired its competitor, RxLive.
RxLive is a concierge telehealth pharmacy service that connects patients with expert pharmacists in a secure, private and personal way. RxLive began in 2017, and over the last seven years, it has made significant investments to build out its technology platform, artificial intelligence and analytics. RxLive sells its medication management platform to other healthcare organizations.
Scriptology is an Atlanta, Georgia-based provider of medication management services intended for improving patient outcomes and lowering the total cost of care. Scriptology is a pre-series A startup that works with risk-bearing providers and insurance companies to improve patient outcomes by involving clinical pharmacists. Started out of Redesign Health, a healthcare venture builder, Scriptology launched to bring a new approach to pharmacy services and medication management by combining an extended clinical pharmacist team with a technology platform to give patients more guidance and support to help them follow their medication plan.
RxLive is now a wholly owned subsidiary of Scriptology. Scriptology CEO Erin Hendrick said RxLive was a direct competitor with a similar mission to deliver medication management services through technology. RxLive’s assets, combined with Scriptology’s strong finances and operations, made the case for the acquisition. It has set the company up for exponential growth, Hendrick said. Scriptology also saw the benefits of acquiring RxLive’s clinical teams and its records of thousands of patient interactions that involved a clinical pharmacist.
RxLive CEO Mark Engelen will sit on the board of Scriptology. RxLive’s clinical teams will stay together and continue to provide RxLive’s services. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this acquisition represents the 181st eHealth transaction of 2024, and the 32nd in the telehealth specialty. There were 60 telehealth deals announced during 2023, and 55 announced during 2022.
